Biocon Biologics Ltd., a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd., has announced the appointment of Deepak Dobriyal as Global Head – Talent & HR Transformation. In this strategic leadership role, Deepak will be responsible for driving the company’s global people agenda, strengthening talent capabilities, and accelerating HR transformation across geographies.
With Biocon Biologics expanding its footprint in regulated and emerging markets, the appointment underscores the company’s focus on building a future-ready workforce aligned with its growth ambitions. Deepak Dobriyal will lead global talent management, leadership development, workforce planning, organizational effectiveness, and digital HR transformation initiatives. He will also play a critical role in fostering a high-performance, purpose-driven culture that supports innovation and operational excellence.
Deepak brings over two decades of rich experience in human resources, talent strategy, and organizational transformation across leading Indian and multinational organizations. Known for his expertise in large-scale HR change management, he has successfully led initiatives in leadership capability building, employee engagement, diversity and inclusion, and HR digitization. His deep understanding of complex, matrixed organizations makes him well-suited to support Biocon Biologics’ evolving global structure.
Commenting on the appointment, Biocon Biologics leadership emphasized that strengthening people and leadership capabilities is central to the company’s long-term success. As the organization scales its biosimilars portfolio and global operations, a strong talent ecosystem will be critical to sustaining innovation, quality, and patient-centric outcomes.
In his new role, Deepak Dobriyal will work closely with global business leaders to align talent strategies with business priorities, build a strong leadership pipeline, and enhance employee experience across the lifecycle. His mandate will also include leveraging digital tools and data-driven insights to modernize HR processes and enable agile decision-making.
This appointment reflects Biocon Biologics’ continued investment in people-centric leadership and reinforces its commitment to building a resilient, inclusive, and high-impact global workforce.